Consistent with this notion, treatment with ACY-1215 reduces the protein level of PPP3CA which is a HSP90 client protein, suggesting that HDAC6 maintains MM cell growth by preventing PPP3CA degradation108. Here, PPP3CA is linked to Miyoshi myopathy.